Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGalliford Try Regulatory News (GFRD)

Share Price Information for Galliford Try (GFRD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 246.00
Bid: 244.00
Ask: 246.00
Change: 6.00 (2.50%)
Spread: 2.00 (0.82%)
Open: 244.00
High: 248.00
Low: 237.00
Prev. Close: 240.00
GFRD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Settlement of AWPR

23 Dec 2019 11:00

RNS Number : 8332X
Galliford Try PLC
23 December 2019
 

 

 

 

 

 

 

Galliford Try plc

Settlement agreed on Aberdeen Western Peripheral Route

 

Galliford Try plc ("Galliford Try"), the housebuilding, regeneration and construction group announces that, following a lengthy period of negotiation, the Aberdeen Western Peripheral Route ("AWPR") joint venture has substantially agreed settlement terms with the client in respect of the final account of this major infrastructure project. As a result of the settlement Galliford Try expects to receive a cash payment of around £32m and incur a write-off of £52m.

 

The settlement brings to a conclusion a complex and challenging project, averting a lengthy and costly litigation process. The settlement also removes a significant distraction and uncertainty, allowing the Construction business to focus on its core business, current and new projects which are expected to deliver improving margins, operating on multiple secured frameworks and in our chosen sectors. 

 

Taken together with an adverse adjudication award on an unrelated historical contract in the period, the Group will report an exceptional write-off of circa £61m at 31 December 2019.

 

The person responsible for making this announcement on behalf of Galliford Try is Kevin Corbett, General Counsel & Company Secretary. This announcement contains inside information for the purposes of article 7 of EU Regulation 596/2014.

 

For further enquiries please contact:

 

Galliford Try

Graham Prothero, Chief Executive 01895 855001

Andrew Duxbury, Finance Director

 

Tulchan Communications

James Macey White 020 7353 4200

Martin Pengelley

Elizabeth Snow

 

 

Galliford Try plc is a leading UK housebuilding, regeneration and construction group. It is listed on the London Stock Exchange and a member of the FTSE 250. Housebuilding - through our Linden Homes business - develops private and affordable homes in prime locations. Galliford Try Partnerships - our regeneration business - delivers mixed-tenure solutions working with housing association, local authority and private sector partners. Operating as Galliford Try and Morrison Construction, our Construction business carries out building and infrastructure with clients in the public, private and regulated sectors. At the end of the last financial year to 30 June 2019, the Group generated revenue of £2.8bn. On 7 November 2019 the Group announced it had entered into an agreement with Bovis Homes Group PLC regarding a combination of Bovis Homes and the Group's housebuilding businesses, Linden Homes and Partnerships & Regeneration. The transaction is expected to complete on 3 January 2020.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCBXLFLKLFEFBK
Date   Source Headline
13th Jun 20247:00 amRNSContract
31st May 20244:00 pmRNSTotal Voting Rights
31st May 20247:00 amRNSContract
23rd May 20247:00 amRNSCapital Markets Event
30th Apr 20244:00 pmRNSTotal Voting Rights
23rd Apr 20244:00 pmRNSDirector/PDMR Shareholding
10th Apr 20245:00 pmRNSHolding(s) in Company
5th Apr 202411:00 amRNSTotal Voting Rights
28th Mar 20247:00 amRNSDirectorate Change
8th Mar 20244:00 pmRNSDirector/PDMR Shareholding
6th Mar 20247:00 amRNSHalf-year Report
4th Mar 20244:00 pmRNSTotal Voting Rights
1st Mar 20247:00 amRNSDirectorate Change
26th Feb 20246:03 pmRNSBlock listing Interim Review
22nd Feb 20247:00 amRNSContract
17th Jan 20247:00 amRNSTrading Statement
30th Nov 20234:00 pmRNSTotal Voting Rights
17th Nov 20237:00 amRNSCompletion of Share Buyback Programme
16th Nov 20234:30 pmRNSHolding(s) in Company
16th Nov 20237:00 amRNSTransaction in Own Shares
10th Nov 20233:00 pmRNSResult of AGM
10th Nov 20237:00 amRNSAGM Statement
9th Nov 20237:00 amRNSAcquisition
8th Nov 20237:00 amRNSDirectorate Change
7th Nov 20237:00 amRNSContract
2nd Nov 20235:51 pmRNSTotal Voting Rights
1st Nov 20237:00 amRNSTransaction in Own Shares
30th Oct 20237:00 amRNSTransaction in Own Shares
27th Oct 20237:00 amRNSTransaction in Own Shares
26th Oct 20239:14 amRNSTransaction in Own Shares
23rd Oct 202311:05 amRNSDirectorate Change
18th Oct 20237:00 amRNSTransaction in Own Shares
13th Oct 20237:00 amRNSTransaction in Own Shares
6th Oct 20233:30 pmRNSAnnual Financial Report
3rd Oct 202310:15 amRNSEmployee Share Trust Trading Plan
2nd Oct 202310:30 amRNSTotal Voting Rights
28th Sep 20233:05 pmRNSDirector/PDMR Shareholding
28th Sep 20233:00 pmRNSDirector/PDMR Shareholding
26th Sep 20234:30 pmRNSDirector/PDMR Shareholding
25th Sep 20234:15 pmRNSDirector/PDMR Shareholding
22nd Sep 20233:00 pmRNSHolding(s) in Company
21st Sep 20232:30 pmRNSBlock listing Interim Review
20th Sep 20237:00 amRNSFinal Results
12th Sep 20237:00 amRNSTransaction in Own Shares
8th Sep 20237:00 amRNSTransaction in Own Shares
7th Sep 20237:00 amRNSTransaction in Own Shares
6th Sep 20237:00 amRNSTransaction in Own Shares
4th Sep 20237:00 amRNSTransaction in Own Shares
1st Sep 202310:30 amRNSTotal Voting Rights
1st Sep 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.